XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Income (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Apr. 27, 2025
Apr. 28, 2024
Net sales: $ 251,060 $ 206,105
Amortization of acquired technology 2,205 2,281
Total cost of sales 119,771 106,513
Gross profit 131,289 99,592
Operating expenses, net:    
Product development and engineering 47,529 41,604
Selling, general and administrative 46,447 52,269
Intangible amortization 147 307
Restructuring 1,199 2,269
Total operating expenses, net 95,322 96,449
Operating income 35,967 3,143
Interest expense (6,582) (23,229)
Interest income 369 542
Non-operating (expense) income, net (2,802) 400
Investment impairments and credit loss reserves, net 0 (1,109)
Income (loss) before taxes and equity method income 26,952 (20,253)
Provision for income taxes 8,653 2,956
Net income (loss) before equity method income 18,299 (23,209)
Equity method income 1,046 50
Net income (loss) $ 19,345 $ (23,159)
Earnings (loss) per share:    
Basic (in dollars per share) $ 0.22 $ (0.36)
Diluted (in dollars per share) $ 0.22 $ (0.36)
Weighted-average number of shares used in computing earnings (loss) per share:    
Basic (in shares) 86,441 64,509
Diluted (in shares) 89,579 64,509
Products    
Net sales: $ 223,776 $ 177,488
Cost of sales: 105,411 91,234
Services    
Net sales: 27,284 28,617
Cost of sales: $ 12,155 $ 12,998